TARA Mind develops a clinician-guided, data-driven collaborative care platform to deliver ketamine-assisted therapy (KAT) and other emerging mental health treatments as an employer-covered benefit. The company focuses on individuals with treatment-resistant mental health disorders and aims to integrate personalized, evidence-based care into self-funded employer benefit plans. TARA Mind maintains a structured real-world evidence dataset to support outcomes and decision-making and emphasizes measurable ROI for employers via reduced medical costs, lower absenteeism, and improved productivity. The firm positions itself as a first mover in the employer benefit space for psychedelic-assisted therapies and seeks to expand affordable access nationwide. Founded in 2022 by Marcus Capone with involvement from Red Cell Partners (Grant Verstandig and Dr. Yisroel Brumer), TARA Mind is organized as a public benefit corporation and is scaling its provider network and employer partnerships. The company recently completed a seed financing round to support that expansion. TARA Mind, founded in 2022, is a Public Benefit Corporation emerging from stealth to expand safe, affordable, and effective access to psychedelic-assisted therapy (PAT). The company has built a network of vetted PAT providers across the US and abroad and is developing proprietary digital measurement-based care tools to ensure safety, optimize outcomes, and enable data-driven, value-based reimbursement. It has codified The TARA Mind Way™ and PTIM™, a clinician-guided framework of Preparation, Treatment, Integration, and Monitoring, to guarantee wraparound services and standardize care. TARA Mind is working with early-adopter employers to add its provider network as a supplemental benefit to existing health plans to reduce equity barriers and drive employer ROI. The company has convened medical advisors from institutions including Harvard, Stanford, and Mount Sinai to help define standards of care. Red Cell Partners announced $3 million in pre-seed funding to fuel the company’s mission and product development.

Total raised

$11M

Funding rounds

2

Latest round

Seed

Latest activity

Jan 2024